Interactions of intracerebroventricular pertussis toxin treatment with the ataxic and hypothermic effects of ethanol

Naunyn Schmiedebergs Arch Pharmacol. 1991 Aug;344(2):252-8. doi: 10.1007/BF00167227.

Abstract

Pretreatment with pertussis toxin (0.5 and 1.0 microgram/animal, i.c.v., seven days prior to testing) reversed the reduction in locomotor activity in the holeboard test caused by administration of the alpha 2-adrenoceptor agonist, medetomidine (0.1 mg/kg, i.p.). Intrinsic behavioral effects of pertussis toxin treatment were also observed, these included a reduction in exploratory head-dipping and an increase in locomotor activity. These doses of pertussis toxin also reduced the ataxia induced by a 2.4 g/kg dose of ethanol. Pertussis toxin treated animals also exhibited a diminished hypothermic response to ethanol (2 g/kg), although the pertussis toxin treated animals had lower body temperatures prior to ethanol administration compared to sham treated animals. Neither the behavioral effect of pertussis holotoxin in the holeboard nor its effects on reversing medetomidine hypolocomotion or ethanol-induced ataxia were seen following administration of the binding oligomer of pertussis toxin which binds to the cell membrane but does not possess the enzymatically active subunit. These findings implicate mechanisms involving pertussis toxin sensitive G-proteins in modulating some behavioral and physiological effects of ethanol.

MeSH terms

  • Animals
  • Ataxia / chemically induced*
  • Body Temperature / drug effects*
  • Ethanol / blood
  • Ethanol / pharmacology*
  • GTP-Binding Proteins / physiology
  • Imidazoles / pharmacology
  • Injections, Intraventricular
  • Male
  • Medetomidine
  • Mice
  • Motor Activity / drug effects
  • Pertussis Toxin*
  • Virulence Factors, Bordetella / pharmacology*

Substances

  • Imidazoles
  • Virulence Factors, Bordetella
  • Ethanol
  • Pertussis Toxin
  • GTP-Binding Proteins
  • Medetomidine